Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term angiogenesis. Found 30 abstracts

no pagination
Voss MH, Bhatt RS, Vogelzang NJ, Fishman M, Alter RS, Rini BI, Beck JT, Joshi M, Hauke R, Atkins MB, Burgess E, Logan TF, Shaffer D, Parikh R, Moazzam N, Zhang X, Glasser C, Sherman ML, Plimack ER. A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma. Cancer. 2019 Apr 05;125(14):2400-8.   PMCID: PMC6602847
Simonelli M, Zucali P, Santoro A, Thomas MB, de Braud FG, Borghaei H, Berlin J, Denlinger CS, Noberasco C, Rimassa L, Kim TY, English PA, Abbattista A, Gallo Stampino C, Carpentieri M, Williams JA. Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase 1 in patients with hepatocellular carcinoma. Ann Oncol. 2016 Sep;27(9):1782-7.
Lopez-Pastrana J, Ferrer LM, Li YF, Xiong X, Xi H, Cueto R, Nelson J, Sha X, Li X, Cannella AL, Imoukhuede PI, Qin X, Choi ET, Wang H, Yang XF. Inhibition of Caspase-1 Activation in Endothelial Cells Improves Angiogenesis: A NOVEL THERAPEUTIC POTENTIAL FOR ISCHEMIA. The Journal of biological chemistry. 2015 Jul 10;290(28):17485-94.   PMCID: 4498083
Bilusic M, Wong YN. Anti-angiogenesis in prostate cancer: knocked down but not out. Asian journal of andrology. 2014 May;16(3):372-7.   PMCID: PMC4023362
Lee S, Goldfinger LE. RLIP76 regulates HIF-1 activity, VEGF expression and secretion in tumor cells, and secretome transactivation of endothelial cells. FASEB J. 2014 Sep;28(9):4158-68.   PMCID: 4139904
Adler EH, Sunkara JL, Patchefsky AS, Koss LG, Oktay MH. Predictors of disease progression in ductal carcinoma in situ of the breast and vascular patterns. Human Pathology. 2012 Apr;43(4):550-6.   PMCID: not NIH funded
de Jesus-Gonzalez N, Robinson E, Penchev R, von Mehren M, Heinrich MC, Tap W, Wang Q, Demetri G, George S, Humphreys BD. Regorafenib Induces Rapid and Reversible Changes in Plasma Nitric Oxide and Endothelin-1. American Journal of Hypertension. 2012 Oct;25(10):1118-23.   PMCID: PMC 3578478
Mackay HJ, Buckanovich RJ, Hirte H, Correa R, Hoskins P, Biagi J, Martin LP, Fleming GF, Morgan R, Wang L, Polintan R, Oza AM. A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia. Gynecologic Oncology. 2012 Apr;125(1):136-40.   PMCID: pmc3303987
Patson B, Cohen RB, Olszanski AJ. Pharmacokinetic evaluation of axitinib. Expert Opinion on Drug Metabolism & Toxicology. 2012 Feb;8(2):259-70.   PMCID: not NIH funded
Turaka A, Buyyounouski MK, Hanlon AL, Horwitz EM, Greenberg RE, Movsas B. Hypoxic Prostate/Muscle PO2 Ratio Predicts for Outcome in Patients With Localized Prostate Cancer: Long-Term Results. International Journal of Radiation Oncology Biology Physics. 2012 Mar;82(3):E433-E439.   PMCID: not NIH funded
Astsaturov IA, Meropol NJ, Alpaugh RK, Burtness BA, Cheng JD, McLaughlin S, Rogatko A, Xu ZH, Watson JC, Weiner LM, Cohen SJ. Phase II and Coagulation Cascade Biomarker Study of Bevacizumab With or Without Docetaxel in Patients With Previously Treated Metastatic Pancreatic Adenocarcinoma. American Journal of Clinical Oncology-Cancer Clinical Trials. 2011 Feb;34(1):70-5.   PMCID: PMC3030655
Bell-McGuinn KM, Matthews CM, Ho SN, Barve M, Gilbert L, Penson RT, Lengyel E, Palaparthy R, Gilder K, Vassos A, McAuliffe W, Weymer S, Barton J, Schilder RJ. A phase II, single-arm study of the anti-alpha 5 beta 1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer. Gynecologic Oncology. 2011 May;121(2):273-9.   PMCID: not NIH funded
Brem SS, Bierman PJ, Brem H, Butowski N, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR, Hesser D, Junck L, Linette GP, Loeffler JS, Maor MH, Michael M, Moots PL, Morrison T, Mrugala M, Nabors LB, Newton HB, Portnow J, Raizer JJ, Recht L, Shrieve DC, Sills AK, Vrionis FD, Wen PY. Central Nervous System Cancers. Journal of the National Comprehensive Cancer Network. 2011 Apr;9(4):352-400.   PMCID: not NIH funded
Sasaroli D, Gimotty PA, Pathak HB, Hammond R, Kougioumtzidou E, Katsaros D, Buckanovich R, Devarajan K, Sandaltzopoulos R, Godwin AK, Scholler N, Coukos G, Stellani P VP. Novel surface targets and serum biomarkers from the ovarian cancer vasculature. Cancer Biology & Therapy. 2011 Aug;12(3):169-80.   PMCID: PMC3230481
Grugan KD, Miller CG, Yao Y, Michaylira CZ, Ohashi S, Klein-Szanto AJ, Diehl A, Herlyn M, Han M, Nakagawa H, Rustgi AK. Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion. Proceedings of the National Academy of Sciences of the United States of America. 2010 Jun;107(24):11026-31.   PMCID: PMC2890722
Mabuchi S, Kawase C, Altomare DA, Morishige K, Hayashi M, Sawada K, Ito K, Terai Y, Nishio Y, Klein-Szanto AJ, Burger RA, Ohmichi M, Testa JR, Kimura T. Vascular Endothelial Growth Factor Is a Promising Therapeutic Target for the Treatment of Clear Cell Carcinoma of the Ovary. Molecular Cancer Therapeutics. 2010 Aug;9(8):2411-22.   PMCID: PMC2941981 [Available on 2011/8/1]
Welch SA, Hirte HW, Elit L, Schilder RJ, Wang L, MacAlpine K, Wright JJ, Oza AM. Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer A Study of the Princess Margaret Hospital Phase II Consortium. International Journal of Gynecological Cancer. 2010 Jul;20(5):787-93.   PMCID: Not required
Akino T, Hida K, Hida Y, Tsuchiya K, Freedman D, Muraki C, Ohga N, Matsuda K, Akiyama K, Harabayashi T, Shinohara N, Nonomura K, Klagsbrun M, Shindoh M. Cytogenetic Abnormalities of Tumor-Associated Endothelial Cells in Human Malignant Tumors. American Journal of Pathology. 2009 Dec;175(6):2657-67.   PMCID: PMC2789618
Boquoi A, Chen T, Enders GH. Chemoprevention of Mouse Intestinal Tumorigenesis by the Cyclin-Dependent Kinase Inhibitor SNS-032. Cancer Prevention Research. 2009 Sep;2(9):800-6.   PMCID: PMC2819381
Horiguchi A, Chen DY, Goodman OB, Zheng R, Shen R, Guan H, Hersh LB, Nanus DM. Neutral endopeptidase inhibits prostate cancer tumorigenesis by reducing FGF-2-mediated angiogenesis. Prostate Cancer and Prostatic Diseases. 2008 Mar;11(1):79-87.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term angiogenesis

angiogenesis bevacizumab expression cancer chemotherapy colorectal-cancer therapy renal-cell carcinoma carcinoma breast-cancer docetaxel antitumor-activity Ovarian cancer oncology-group tumor markers solid tumors endothelial growth-factor phase-ii Cell Proliferation CELL-MIGRATION mice po-2 lentivirus primary peritoneal brain metastases Breast carcinoma Pf-03446962 cell lung-carcinoma multikinase renal cell carcinoma dna methylation Brachytherapy guidelines medulloblastoma Trap) gene-expression progression genes liposomal clinical trials Urology & Nephrology biochemical failure ADVANCED SOLID TUMORS growth contrast-enhanced mri hypertension IN-VIVO Phase II diastolic blood-pressure contribute Carcinosarcoma Hypoxia gamma-knife surgery Gemcitabine tumorigenesis plus gemcitabine gemcitabine plus alpha(5)beta(1) integrin TUMOR-GROWTH mixed mullerian tumors Apoptosis ifosfamide tpr-met VEGF density ulcerative-colitis progenitor cells basic fibroblast growth factor biomarkers Prostate cancer brain tumor lung-cancer phase-iii trial pancreatic adenocarcinoma metabolism PROGRESSION plasma-levels CA125 Platinum resistant NCCN Guidelines stroma esophageal cancer cancer-associated fibroblasts-tumor microenvironment-organotypic culture-c-met PTEN (JNCCN 2011 caspase 1 (CASP1) Hypoxia-Inducible Factor 1 platinum Volociximab dexamethasone Vascular Endothelial Growth Factor A pathway Western Blotting metastatic PROMOTER Carcinoma progression PLUS PREDNISONE high-dose Uterine leiomyosarcoma blood pressure antiangiogenic therapy-endothelin-1-hypertension-nitric oxide NCCN Clinical Practice Guidelines RNA p16(ink4a) gastrointestinal stromal tumors TGF-beta receptor carcinogenesis coagulation prostate cancer RANDOMIZED-TRIAL glioblastoma vascular angiogenesis inhibitor Transcriptional Activation serum Ductal carcinoma in situ radiation-therapy phase-ii trial pathology Andrology Eppendorf system hepatocellular carcinoma activin-receptor like kinase-1 colon-cancer circulating tumor-cells radiotherapy plus concomitant hematopoietic stem Angiogenesis soft-tissue sarcomas Alk-1 uterus alpha 5 beta 1 integrin metaanalysis growth-factor brain radiation-therapy LENTIVIRAL VECTORS ovarian PROGRESSION-FREE SURVIVAL TYROSINE KINASE in-vitro Phosphatidylinositol 3-Kinases biomarker average-risk medulloblastoma cytology diagnostics Cell Hypoxia FIBROBLAST GROWTH FACTOR-2 Experimental Melanoma Biochemical failure vessels doxorubicin
Last updated on Monday, November 04, 2019